(RNO) Renault - Ratings and Ratios
Passenger Cars, Light Commercial Vehicles, Used Vehicles, Spare Parts, Mobility
Dividends
| Dividend Yield | 4.72% |
| Yield on Cost 5y | 7.09% |
| Yield CAGR 5y | 196.65% |
| Payout Consistency | 69.7% |
| Payout Ratio | 68.0% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 30.2% |
| Value at Risk 5%th | 48.5% |
| Relative Tail Risk | -2.45% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.92 |
| Alpha | -36.23 |
| CAGR/Max DD | -0.05 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.508 |
| Beta | 0.274 |
| Beta Downside | 0.391 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.51% |
| Mean DD | 17.68% |
| Median DD | 16.62% |
Description: RNO Renault January 02, 2026
Renault SA (PA:RNO) designs, manufactures, sells, repairs, maintains, and leases motor vehicles across Europe, Eurasia, Africa, the Middle East, Asia-Pacific, and the Americas. Its operations are organized into three segments: Automotive (passenger cars, light commercial vehicles, tractors, farm and construction equipment under Renault, Dacia, Alpine, Renault Korea Motors, and Mobilize brands), Sales Financing (Mobilize Financial Services offering credit, rental, and service contracts), and Mobility Services (Mobilize Beyond Automotive delivering EV-focused mobility and energy solutions). The group also provides used-vehicle sales, spare-parts distribution, B2B powertrain services, and advanced engineering R&D.
As of 2023, Renault reported revenue of roughly €46 billion and a net loss of €1.4 billion, reflecting a transition cost toward electrification; EV sales grew 38% year-over-year, now representing about 15% of total deliveries. Key economic drivers include EU CO₂-emission standards, which pressure legacy ICE volumes, and the rollout of subsidies for electric vehicles that boost demand for Mobilize’s services. The Renault-Nissan-Mitsubishi alliance remains a strategic lever, offering shared platforms and cost synergies that can mitigate supply-chain volatility.
For a deeper quantitative view of Renault’s valuation metrics and scenario analysis, you may find ValueRay’s dashboard useful.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (-10.33b TTM) > 0 and > 6% of Revenue (6% = 6.56b TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 3.13pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 2.10% (prev 10.71%; Δ -8.62pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 11.02b > Net Income -10.33b (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.03 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (273.5m) change vs 12m ago -0.83% (target <= -2.0% for YES) |
| Gross Margin 19.12% (prev 18.37%; Δ 0.74pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 92.38% (prev 70.70%; Δ 21.68pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -8.70 (EBITDA TTM -29.0m / Interest Expense TTM 651.0m) >= 6 (WARN >= 3) |
Altman Z'' -0.33
| (A) 0.02 = (Total Current Assets 88.20b - Total Current Liabilities 85.91b) / Total Assets 116.94b |
| (B) -0.10 = Retained Earnings (Balance) -11.19b / Total Assets 116.94b |
| (C) -0.05 = EBIT TTM -5.67b / Avg Total Assets 118.43b |
| (D) 0.17 = Book Value of Equity 16.43b / Total Liabilities 96.29b |
| Total Rating: -0.33 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 46.58
| 1. Piotroski 5.50pt |
| 2. FCF Yield 7.58% |
| 3. FCF Margin 5.07% |
| 4. Debt/Equity 3.52 |
| 5. Debt/Ebitda data missing |
| 6. ROIC - WACC (= -4.41)% |
| 7. RoE -37.40% |
| 8. Rev. Trend 38.21% |
| 9. EPS Trend -46.64% |
What is the price of RNO shares?
Over the past week, the price has changed by -4.43%, over one month by -10.61%, over three months by -2.73% and over the past year by -23.50%.
Is RNO a buy, sell or hold?
What are the forecasts/targets for the RNO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 45.3 | 35.6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 38.4 | 14.9% |
RNO Fundamental Data Overview January 14, 2026
P/E Forward = 6.1958
P/S = 0.1702
P/B = 0.4927
P/EG = 0.8055
Beta = 0.86
Revenue TTM = 109.40b EUR
EBIT TTM = -5.67b EUR
EBITDA TTM = -29.0m EUR
Long Term Debt = 5.49b EUR (from longTermDebt, last quarter)
Short Term Debt = 64.05b EUR (from shortTermDebt, last quarter)
Debt = 70.08b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 51.15b EUR (from netDebt column, last quarter)
Enterprise Value = 73.17b EUR (9.69b + Debt 70.08b - CCE 6.60b)
Interest Coverage Ratio = -8.70 (Ebit TTM -5.67b / Interest Expense TTM 651.0m)
EV/FCF = 13.19x (Enterprise Value 73.17b / FCF TTM 5.55b)
FCF Yield = 7.58% (FCF TTM 5.55b / Enterprise Value 73.17b)
FCF Margin = 5.07% (FCF TTM 5.55b / Revenue TTM 109.40b)
Net Margin = -9.44% (Net Income TTM -10.33b / Revenue TTM 109.40b)
Gross Margin = 19.12% ((Revenue TTM 109.40b - Cost of Revenue TTM 88.49b) / Revenue TTM)
Gross Margin QoQ = 17.69% (prev 18.62%)
Tobins Q-Ratio = 0.63 (Enterprise Value 73.17b / Total Assets 116.94b)
Interest Expense / Debt = 0.24% (Interest Expense 170.0m / Debt 70.08b)
Taxrate = 42.07% (647.0m / 1.54b)
NOPAT = -3.28b (EBIT -5.67b * (1 - 42.07%)) [loss with tax shield]
Current Ratio = 1.03 (Total Current Assets 88.20b / Total Current Liabilities 85.91b)
Debt / Equity = 3.52 (Debt 70.08b / totalStockholderEquity, last quarter 19.88b)
Debt / EBITDA = -1764 (out of range, set to none) (Net Debt 51.15b / EBITDA -29.0m)
Debt / FCF = 9.22 (Net Debt 51.15b / FCF TTM 5.55b)
Total Stockholder Equity = 27.61b (last 4 quarters mean from totalStockholderEquity)
RoA = -8.72% (Net Income -10.33b / Total Assets 116.94b)
RoE = -37.40% (Net Income TTM -10.33b / Total Stockholder Equity 27.61b)
RoCE = -17.11% (EBIT -5.67b / Capital Employed (Equity 27.61b + L.T.Debt 5.49b))
RoIC = -3.45% (negative operating profit) (NOPAT -3.28b / Invested Capital 95.25b)
WACC = 0.96% (E(9.69b)/V(79.76b) * Re(6.92%) + D(70.08b)/V(79.76b) * Rd(0.24%) * (1-Tc(0.42)))
Discount Rate = 6.92% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.96%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈4.10b ; Y1≈5.06b ; Y5≈8.62b
Fair Price DCF = 689.2 (EV 250.87b - Net Debt 51.15b = Equity 199.72b / Shares 289.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -46.64 | EPS CAGR: -87.25% | SUE: -4.0 | # QB: 0
Revenue Correlation: 38.21 | Revenue CAGR: 3.64% | SUE: 0.91 | # QB: 1
EPS next Year (2026-12-31): EPS=7.92 | Chg30d=-0.034 | Revisions Net=-2 | Growth EPS=+131.9% | Growth Revenue=+2.1%